These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23997284)

  • 41. Parental Consent for the Use of Residual Newborn Screening Bloodspots: Respecting Individual Liberty vs Ensuring Public Health.
    Bayefsky MJ; Saylor KW; Berkman BE
    JAMA; 2015 Jul; 314(1):21-2. PubMed ID: 26053685
    [No Abstract]   [Full Text] [Related]  

  • 42. Storage and use of Newborn Screening Blood Specimens for Research: Assessing Public Opinion in Illinois.
    Hart A; Petros M; Charrow J; Nash C; Wicklund C
    J Genet Couns; 2015 Jun; 24(3):482-90. PubMed ID: 25410141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inborn errors of metabolism and expanded newborn screening: review and update.
    Mak CM; Lee HC; Chan AY; Lam CW
    Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation of Predictors of Newborn Screening Refusal in a Large Birth Cohort in North Dakota, USA.
    Njau G; Odoi A
    Matern Child Health J; 2019 Jan; 23(1):92-99. PubMed ID: 30014377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. False-positive newborn screening result and future health care use in a state Medicaid cohort.
    Tarini BA; Clark SJ; Pilli S; Dombkowski KJ; Korzeniewski SJ; Gebremariam A; Eisenhandler J; Grigorescu V
    Pediatrics; 2011 Oct; 128(4):715-22. PubMed ID: 21930552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Research use of leftover newborn bloodspots: attitudes of Canadian geneticists regarding storage and informed consent requirements.
    Richer J; Ghebremichael MS; Chudley AE; Robinson WM; Wilfond BS; Solomon MZ
    Genet Med; 2011 Apr; 13(4):305-13. PubMed ID: 20921895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Universal newborn screening: knowledge, attitudes, and satisfaction among public health professionals.
    Dunn L; Gordon K; Sein J; Ross K
    South Med J; 2012 Apr; 105(4):218-22. PubMed ID: 22475673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Financing newborn screening: sources, issues, and future considerations.
    Therrell BL; Williams D; Johnson K; Lloyd-Puryear MA; Mann MY; Ramos LR
    J Public Health Manag Pract; 2007; 13(2):207-13. PubMed ID: 17299328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cystic fibrosis newborn screening: a model for neuromuscular disease screening?
    Scully MA; Farrell PM; Ciafaloni E; Griggs RC; Kwon JM
    Ann Neurol; 2015 Feb; 77(2):189-97. PubMed ID: 25425541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Newborn screening for severe combined immunodeficiency: Evaluation of a commercial T-cell receptor excision circle-based method in Victorian dried blood spots.
    Richards S; Pitt J; Choo S
    J Paediatr Child Health; 2018 Jan; 54(1):14-19. PubMed ID: 28861919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Newborn blood spot screening (NBS) in Germany : Status quo and presentation of a concept for further development].
    Nennstiel U; Odenwald B; Throner V; Blankenstein O; Vieth A; Ratzel R; Coenen M; Brockow I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Nov; 66(11):1195-1204. PubMed ID: 37815611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Newborn screening: education, consent, and the residual blood spot. The position of the national society of genetic counselors.
    Blout C; Walsh Vockley C; Gaviglio A; Fox M; Croke B; Williamson Dean L;
    J Genet Couns; 2014 Feb; 23(1):16-9. PubMed ID: 23881473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parental permission for pilot newborn screening research: guidelines from the NBSTRN.
    Botkin JR; Lewis MH; Watson MS; Swoboda KJ; Anderson R; Berry SA; Bonhomme N; Brosco JP; Comeau AM; Goldenberg A; Goldman E; Therrell B; Levy-Fisch J; Tarini B; Wilfond B;
    Pediatrics; 2014 Feb; 133(2):e410-7. PubMed ID: 24394680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parental consent for newborn screening in southern Taiwan.
    Huang MC; Lee CK; Lin SJ; Lu IC
    J Med Ethics; 2005 Nov; 31(11):621-4. PubMed ID: 16269553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Storage policies and use of the Danish Newborn Screening Biobank.
    Nørgaard-Pedersen B; Hougaard DM
    J Inherit Metab Dis; 2007 Aug; 30(4):530-6. PubMed ID: 17632694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mandatory newborn screening in the United States: History, current status, and existential challenges.
    McCandless SE; Wright EJ
    Birth Defects Res; 2020 Mar; 112(4):350-366. PubMed ID: 32115905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An evaluation of pregnant women's knowledge and attitudes about newborn bloodspot screening.
    Fitzgerald C; Heery E; Conneally N; Linnane B; George S; Fitzpatrick P
    Midwifery; 2017 Feb; 45():21-27. PubMed ID: 27978478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Pulse Oximetry Screening Rates Among the Midwife-Attended Out-of-Hospital Birth Community in Michigan.
    Withrow E; Fussman C; Thompson K; Kleyn M
    J Midwifery Womens Health; 2019 Jul; 64(4):421-426. PubMed ID: 31347781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ethical, legal and social issues in newborn screening in the United States.
    Therrell BL
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():52-8. PubMed ID: 15906695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing public attitudes on the retention and use of residual newborn screening blood samples: a focus group study.
    Rothwell E; Anderson R; Goldenberg A; Lewis MH; Stark L; Burbank M; Wong B; Botkin JR
    Soc Sci Med; 2012 Apr; 74(8):1305-9. PubMed ID: 22398141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.